Skip to main navigation Skip to search Skip to main content

Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in Mycobacterium tuberculosis Complex Isolates in England From 2017 Through 2023

  • Elena Ferran
  • , Cathleen Chan
  • , Noorann Sheikh
  • , Martin Dedicoat
  • , Eliza Alexander
  • , Ana Gibertoni-Cruz
  • , James Brown
  • , Esther Robinson
  • , Marc Lipman*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Fluoroquinolones are increasingly important for anti-tuberculosis (TB) treatment. Identifying fluoroquinolone resistance (FR) is essential. Using sequencing data from over 16 000 unselected isolates, this first English survey of FR, found it present in 1.4% overall and 23.9% of multidrug-resistant TB. Routine sequencing allows clinically-relevant resistance surveillance and should be widely adopted.

Original languageEnglish
Pages (from-to)660-662
Number of pages3
JournalClinical Infectious Diseases
Volume80
Issue number3
DOIs
Publication statusPublished - 15 Mar 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Mycobacterium tuberculosis
  • drug therapy
  • fluoroquinolone resistance
  • whole-genome sequencing

Fingerprint

Dive into the research topics of 'Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in Mycobacterium tuberculosis Complex Isolates in England From 2017 Through 2023'. Together they form a unique fingerprint.

Cite this